We are live on
!
Find out more
Vanguard Capital Management Portfolio holdings
AUM
$4.68T
This Fund
S&P 500
This Quarter
Est. Return
+26.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.68T
AUM Growth
+$637B
(+16%)
Cap. Flow
+$33.9B
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
32.56%
Holding
4,163
New
102
Increased
2,573
Reduced
1,196
Closed
71
Avg Time Held
1
quarter
Top 10 Avg Time Held
0.9
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HONA
Honeywell Aerospace
HONA
|
+$4.57B |
| 2 |
SPCX
SpaceX
SPCX
|
+$4.51B |
| 3 |
Marvell Technology
MRVL
|
+$3.77B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.69B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$4.59B |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$1.69B |
| 3 |
Salesforce
CRM
|
+$1.28B |
| 4 |
JPMorgan Chase
JPM
|
+$1.15B |
| 5 |
HOLX
Hologic
HOLX
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.14% |
| 2 | Financials | 12.19% |
| 3 | Industrials | 9.6% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Discretionary | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3701
Nutriband
NTRB
$88.5M
| $558K | ﹤0.01% |
174,927
| – | – |
2026 Q1
1 quarter
|
|
3702
Passage Bio
PASG
$13.3M
| $556K | ﹤0.01% |
113,964
| – | – |
2026 Q1
1 quarter
|
|
|
TTRX
3703
Turn Therapeutics
TTRX
$405M
| $542K | ﹤0.01% |
74,301
+24,851
| +50% | +$115K |
2026 Q1
1 quarter
|
|
3704
Skye Bioscience
SKYE
$7.44M
| $529K | ﹤0.01% |
95,485
-72
| -0.1% | -$453 |
2026 Q1
1 quarter
|
|
3705
Live Ventures
LIVE
$23.3M
| $528K | ﹤0.01% |
55,012
| – | – |
2026 Q1
1 quarter
|
|
3706
Cryo-Cell International
CCEL
$32.2M
| $526K | ﹤0.01% |
164,976
+3,452
| +2% | +$12.3K |
2026 Q1
1 quarter
|
|
3707
Canterbury Park Holding Corp
CPHC
$81.6M
| $511K | ﹤0.01% |
32,415
-101
| -0.3% | -$1.59K |
2026 Q1
1 quarter
|
|
3708
Natural Alternatives International
NAII
$9.27M
| $504K | ﹤0.01% |
210,880
| – | – |
2026 Q1
1 quarter
|
|
3709
Willamette Valley Vineyards
WVVI
$9.81M
| $499K | ﹤0.01% |
198,896
| – | – |
2026 Q1
1 quarter
|
|
|
NOMA
3710
NOMADAR Corp
NOMA
$34.7M
| $499K | ﹤0.01% |
133,058
+1,200
| +0.9% | +$4.38K |
2026 Q1
1 quarter
|
|
3711
Daxor
DXR
$62M
| $496K | ﹤0.01% |
48,831
+551
| +1% | +$5.57K |
2026 Q1
1 quarter
|
|
3712
TOMI Environmental Solutions
TOMZ
$11.2M
| $495K | ﹤0.01% |
200,285
-26,129
| -12% | -$57.9K |
2026 Q1
1 quarter
|
|
3713
Jasper Therapeutics
JSPR
$18.8M
| $493K | ﹤0.01% |
1,172,021
-576
| -0% | -$431 |
2026 Q1
1 quarter
|
|
3714
Ark Restaurants
ARKR
$16.2M
| $491K | ﹤0.01% |
83,865
| – | – |
2026 Q1
1 quarter
|
|
3715
Lake Shore Bancorp
LSBK
$144M
| $489K | ﹤0.01% |
27,442
+3,249
| +13% | +$51.9K |
2026 Q1
1 quarter
|
|
3716
PSQ Holdings
PSQH
$17.5M
| $487K | ﹤0.01% |
80,537
+4,111
| +5% | +$36.4K |
2026 Q1
1 quarter
|
|
|
NAKA
3717
Nakamoto Inc
NAKA
$173M
| $487K | ﹤0.01% |
123,165
-445
| -0.4% | -$2.97K |
2026 Q1
1 quarter
|
|
3718
NextTrip
NTRP
$29.4M
| $481K | ﹤0.01% |
224,650
+97,332
| +76% | +$248K |
2026 Q1
1 quarter
|
|
|
AXIL
3719
AXIL Brands
AXIL
$42.1M
| $472K | ﹤0.01% |
70,379
+10,687
| +18% | +$72.4K |
2026 Q1
1 quarter
|
|
3720
Corvex Inc
MOVE
$368M
| $468K | ﹤0.01% |
21,576
+13,223
| +158% | +$234K |
2026 Q1
1 quarter
|
|
3721
Modular Medical
MODD
$16.5M
| $464K | ﹤0.01% |
103,182
+47,265
| +85% | +$215K |
2026 Q1
1 quarter
|
|
|
EXOZ
3722
eXoZymes Inc
EXOZ
$53.7M
| $464K | ﹤0.01% |
54,985
+32,795
| +148% | +$309K |
2026 Q1
1 quarter
|
|
|
VHUB
3723
VenHub Global
VHUB
$46.3M
| $462K | ﹤0.01% |
439,592
+185,281
| +73% | +$198K |
2026 Q1
1 quarter
|
|
3724
XBiotech
XBIT
$66.8M
| $460K | ﹤0.01% |
200,182
-789
| -0.4% | -$1.91K |
2026 Q1
1 quarter
|
|
|
BTLN
3725
Brightline Interactive
BTLN
$14.1M
| $455K | ﹤0.01% |
73,898
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
Vanguard Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Capital Management held 4,163 positions worth $4.68T, up 16% from $4.04T the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 4.2%. Vanguard Capital Management opened 102 new positions and exited 71, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Vanguard Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 20,693,166 shares worth $4.57B.
- Vanguard Capital Management added most to Marvell Technology in Q2 2026, an estimated $3.77B increase.
- Vanguard Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $4.59B.
- Vanguard Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.69B.
- Vanguard Capital Management's ten largest holdings make up 33% of its $4.68T portfolio in Q2 2026.
- Vanguard Capital Management opened 102 new positions and closed 71 in Q2 2026.
- Vanguard Capital Management's portfolio value rose 16% quarter-over-quarter to $4.68T.
Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.